Common-Size Balance Sheet: Assets
Paying user area
Try for free
Elevance Health Inc. pages available for free this week:
- Income Statement
- Cash Flow Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Net Profit Margin since 2005
- Current Ratio since 2005
- Price to Sales (P/S) since 2005
- Analysis of Revenues
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Elevance Health Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Elevance Health Inc., common-size consolidated balance sheet: assets
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The asset allocation of the company demonstrates notable shifts between 2021 and 2025. Current assets experienced initial growth, peaking in 2023, before declining, while noncurrent assets exhibited a more fluctuating pattern. Within current assets, the composition also underwent changes, with varying trends observed across different components.
- Liquidity and Current Assets
- The proportion of assets held as cash and cash equivalents increased from 5.01% in 2021 to 7.81% in 2025, indicating a growing emphasis on liquid assets. Premium receivables also showed an increasing trend, rising from 5.83% to 8.29% over the same period. Other receivables and other current assets also increased, though at a slower pace. However, the overall percentage of current assets decreased from 52.45% in 2023 to 50.43% in 2024, then recovered slightly to 51.86% in 2025. This suggests a shift in asset allocation towards longer-term holdings despite the increases in individual current asset components.
- Investments
- Fixed maturity securities experienced a decrease as a percentage of total assets, falling from 26.95% in 2021 to 21.30% in 2025. Equity securities saw a significant decline from 1.93% to 0.61% over the period. Conversely, long-term investments increased substantially, rising from 6.01% in 2021 to 9.84% in 2025, and other invested assets also showed a marked increase, growing from 5.36% to 8.92%. This indicates a strategic move towards longer-duration investments.
- Long-Term Assets
- Goodwill remained relatively stable, fluctuating between 23.73% and 24.86% of total assets. Other intangible assets decreased from 10.89% in 2021 to 9.22% in 2025. Property and equipment, net, experienced a slight decline, decreasing from 4.02% to 3.85%. The proportion of noncurrent assets generally remained around 48-49% of total assets, with a slight dip in 2022 and 2023.
- Assets Held for Sale
- Assets held for sale represented 0.42% of total assets in 2024, suggesting a potential divestiture or restructuring activity during that year. This item was not present in other years examined.
In summary, the company’s asset allocation shifted over the five-year period, with a relative decrease in certain securities and an increase in long-term investments and liquid assets. The changes suggest a potential strategic repositioning of the asset base, balancing liquidity with longer-term growth opportunities.